CAS: 1607837-31-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | CCT-251921 REF: 54-BUP14305CAS: 1607837-31-9 | ≥95% | 818,00 €~5.812,00 € | Vie 09 May 25 |
 | CCT-251921 REF: 3D-HPC83731CAS: 1607837-31-9 | Min. 95% | A consultar | Vie 20 Jun 25 |
 | CCT-251921 REF: TM-T14901CAS: 1607837-31-9 | 97.74% | 95,00 €~1.074,00 € | Jue 10 Jul 25 |
Ref: 54-BUP14305
| 1g | 5.812,00 € | ||
| 25mg | 818,00 € | ||
| 50mg | 1.153,00 € | ||
| 100mg | 1.454,00 € | ||
| 500mg | 2.908,00 € |
Entrega estimada en Estados Unidos, el Viernes 9 de Mayo de 2025
CCT-251921
CAS:1607837-31-9
Please enquire for more information about CCT-251921 including the price, delivery time and more detailed …
Fórmula:
C21H23ClN6O
Pureza:
Min. 95%
Peso molecular:
410.9 g/mol
Ref: 3D-HPC83731
| 5mg | 760,00 € | ||
| 10mg | 1.145,00 € | ||
| 25mg | 1.867,00 € | ||
| 50mg | 2.910,00 € |
Entrega estimada en Estados Unidos, el Viernes 20 de Junio de 2025
CCT-251921
CAS:1607837-31-9
CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibitor (IC50: 2.3 nM).
Fórmula:
C21H23ClN6O
Pureza:
97.74%
Forma y color:
Solid
Peso molecular:
410.9
Ref: TM-T14901
| 1mg | 95,00 € | ||
| 5mg | 221,00 € | ||
| 10mg | 324,00 € | ||
| 25mg | 548,00 € | ||
| 50mg | 785,00 € | ||
| 100mg | 1.074,00 € | ||
| 1mL*10mM (DMSO) | 202,00 € |
Entrega estimada en Estados Unidos, el Jueves 10 de Julio de 2025
